SINTX Technologies (SINT) Enterprise Value to EBITDA Ratio
Sintx Technologies (SINT) is in a maturity phase, expanding the application of ceramics in energy, defense, and medicine. High revenue predictability is based on the uniqueness of the components supplied for prosthetics. The current EV/EBITDA ratio is 0.00. This stock price chart demonstrates the business's resilience to economic cycles, as demand for orthopedic surgeries remains stable regardless of the market phase.
Comprehensive metric breakdowns and analytics for sintx.com (SINT)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
- financial results and valuation multiples details:
SINT - Net Financial Result|Projected Future Earnings Sintx Technologies|SINT - Price to Earnings Ratio|Forward P/E Multiple Sintx Technologies, Inc.|SINT - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SINT|SINT - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Sintx Technologies|SINT - Earnings per share for the trailing year|Quarterly EPS earnings growth sintx.com|SINT - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Sintx Technologies
Analysis of all company metrics:SINTX Technologies SINT
The EV/EBITDA multiple compares the total enterprise value, including net debt, with operating profit before depreciation and amortization, excluding the impact of the tax regime and financing structure. For Sintx Technologies (SINT), the EV/EBITDA valuation level reflects the ability of high-margin ceramics patents to cover capital expenditures for the slow expansion of plants, determining the company's actual resilience to its debt load.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio SI-BONE Medical SIBN|EV/EBITDA Multiple OFIX (Orthofix Medical Inc.)|EV/EBITDA Multiple bioventus.com BVS|KIDS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA (Strata Critical Medical Corp) - Enterprise Value to EBITDA Ratio|Carlsmed Medical - Business Value to Operating Income Before Depreciation|RXST (RxSight, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA ClearPoint CLPT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stereotaxis (STXS)|Neuronetics Inc. (STIM) - Enterprise Value to EBITDA Multiple|Sight Sciences, Inc - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple orchestrabiomed.com OBIO|Anika - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio inspiremd.com NSPR|zhjmedical.com (ZJYL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio VANI (Vivani Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Xtant Medical Holdings, Inc.|Enterprise Value to EBITDA Ratio NeuroOne Medical Technologies Corp. (NMTC)|EV/EBITDA Multiple MODD|MYO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envoy Medical COCH|VVOS: Enterprise Value to Operating Income Before Depreciation|NVNO: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|ReWalk Robotics Ltd. (LFWD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|AMIX - Total Company Value to Operating Income Before Depreciation Ratio|IVF (INVO Fertility) - EV/EBITDA Multiple|Bone Biologics Corp. (BBLG) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Axonics Modulation Technologies (AXNX)|Biolase Inc. - Enterprise Value to Operating Income Before Depreciation|Dynatronics - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio FNA (Paragon 28 Inc.)|INVO: Enterprise Value to EBITDA Ratio
